close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TVTX

Recent news which mentions TVTX

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Tickers ABCM ACRS ADM AGRO
Tags BZI/Ratings PGY Initiation
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Tickers NVFY OCUL ONDS OPK
Tags OPK RDI TRKA
From Benzinga
4 Analysts Have This to Say About Travere Therapeutics
Tickers TVTX
Tags BZI/AAR Analyst Ratings Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
Tickers AKTX ALGT ALK AOMR
Tags SBUX SHO Intraday Update
From Benzinga
Where Travere Therapeutics Stands With Analysts
Tickers TVTX
Tags Benzinga Market News TVTX
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tickers SONN SOUN STOK STRC
Tags BZI/ftw STRC TOI
From Benzinga
Travere Therapeutics Earnings Perspective: Return On Capital Employed
Tickers TVTX
Tags Benzinga Earnings Market News
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Tickers APLS ARDX AZN FOLD
Tags TVTX JNJ SCYX
From Benzinga
Recap: Travere Therapeutics Q3 Earnings
Tickers TVTX
Tags Benzinga BZI/Recaps Market News
From Benzinga
Earnings Scheduled For October 27, 2022
Tickers OIS ONTO OPCH OPI
Tags OPRA TMUS WRLD
From Benzinga
Earnings Outlook For Travere Therapeutics
Tickers TVTX
Tags BZI/EP TVTX Market News
From Benzinga
Analyst Cuts Price On Travere Therapeutics Citing Expected Delayed PDUFA
Tickers TVTX
Tags Movers TVTX Analyst Ratings
From Benzinga
121 Stocks That Hit Their 52-Week Low
Tickers ACHV ACST AMBP ANGI
Tags SFT PACK VAPO
From Benzinga
Expert Ratings for Travere Therapeutics
Tickers TVTX
Tags BZI/AAR Analyst Ratings Benzinga
From Benzinga
FDA Requests For Additional Monitoring For Travere Therapeutics' Sparsentan In Rare Kidney Disease
Tickers TVTX
Tags Benzinga Market News Movers
From Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Tickers BTTX FSTR HPK LAZY
Tags RILY LNKB XOM
From InvestorPlace
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Tickers BLTE BNTX CUE GERN
Tags Biotech Catalysts / EOD Summary BLTE GERN
From Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
Tickers CSLLY TVTX
Tags General Biotech Benzinga
From Benzinga
Travere Therapeutics Return On Capital Employed Overview
Tickers TVTX
Tags BZI/ROCE TVTX Market News
From Benzinga
H.C. Wainwright reduces Travere Therapeutics (TVTX) PT’s price to $42
Tickers TVTX
Tags News TVTX Analyst Rating
From Best Stocks
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Tickers ABUS ACAD ADAP AGIO
Tags VIR AUPH NBIX
From Benzinga
Recap: Travere Therapeutics Q2 Earnings
Tickers TVTX
Tags News Market News Earnings
From Benzinga
FDA Says Travere's Sparsentan Data Not Sufficient For Accelerated Approval In One Indication
Tickers TVTX
Tags Movers TVTX Health Care
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers BCLI CASI CCRN ENVB
Tags CCRN XCUR CASI
From Benzinga
4 Analysts Have This to Say About Travere Therapeutics
Tickers TVTX
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Where Travere Therapeutics Stands With Analysts
Tickers TVTX
Tags TVTX Benzinga Market News
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ABIO ADAG CASI CYCC
Tags ITRM ADAG PTIX
From Benzinga
Analyst Ratings for Travere Therapeutics
Tickers TVTX
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Travere Therapeutics: Here's What You Need To Know
Tickers TVTX
Tags TVTX Benzinga Market News
From Benzinga
FDA Accepts Travere Therapeutics' NDA for Sparsentan with Priority Review
Tickers TVTX
Tags TVTX FDA News
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today